Theracys (Intravesical)
Generic name:bacillus of calmette and guerin vaccine, live [ Intravesical-route ]
Drug class:Miscellaneous antineoplastics
Medically reviewed by Drugs.com. Last updated on Jun 5, 2022.
Bacillus of Calmette and Guérin (BCG) infections have been reported in health care workers and in patients because of exposure to the vaccine during preparation and administration. Serious and fatal disseminated BCG infections have occurred with intravesical administration . Manifestations of disseminated infection may not develop for months or years after therapy as BCG may persist in the urinary tract for several months after treatment . TheraCys(R) and TICE(R) BCG contain live attenuated mycobacteria and because of the potential risk for transmission, they should be prepared, handled, and disposed of as a biohazard material .
The TheraCys brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Commonly used brand name(s)
In the U.S.
- Theracys
- Tice BCG
Available Dosage Forms:
- Powder for Suspension
Therapeutic Class: Vaccine, Live
Uses for Theracys
Bacillus Calmette-Guérin (BCG) is used as a solution that is run through a tube (instilled through a catheter) into the bladder to treat bladder cancer. The exact way it works against cancer is not known, but it may work by stimulating the body's immune system.
BCG is to be administered only by or under the immediate supervision of your doctor.
Before using Theracys
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
There is no specific information comparing use of BCG for treatment of cancer in children with use in other age groups.
Geriatric
This medicine has been tested and has not been shown to cause different side effects or problems in older people than it does in younger adults.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose,..
